Team:SDU-Denmark/Tour26

From 2014.igem.org

(Difference between revisions)
Line 8: Line 8:
<style type="text/css">
<style type="text/css">
.tg  {border-collapse:collapse;border-spacing:0;border:none;}
.tg  {border-collapse:collapse;border-spacing:0;border:none;}
-
.tg td{font-family:Arial, sans-serif;font-size:14px;padding:1px 5px;border-style:solid;border-width:0px;overflow:hidden;word-break:normal;}
+
.tg td{font-family:Arial, sans-serif;font-size:14px;padding:7px 5px;border-style:solid;border-width:0px;overflow:hidden;word-break:normal;}
-
.tg th{font-family:Arial, sans-serif;font-size:14px;font-weight:normal;padding:1px 5px;border-style:solid;border-width:0px;overflow:hidden;word-break:normal;}
+
.tg th{font-family:Arial, sans-serif;font-size:14px;font-weight:normal;padding:7px 5px;border-style:solid;border-width:0px;overflow:hidden;word-break:normal;}
-
.tg .tg-u8t5{font-family:Tahoma, Geneva, sans-serif !important;;text-align:center}
+
.tg .tg-s6z2{text-align:center}
.tg .tg-s6z2{text-align:center}
.tg .tg-e3zv{font-weight:bold}
.tg .tg-e3zv{font-weight:bold}
Line 35: Line 34:
   </tr>
   </tr>
   <tr>
   <tr>
-
     <td class="tg-031e">ETH_Zurich_2014></td>
+
     <td class="tg-031e">ETH_Zurich_2014</td>
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
Line 45: Line 44:
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
     <td class="tg-s6z2"><br></td>
-
  </tr>
 
-
  <tr>
 
-
    <td class="tg-031e"><br></td>
 
-
    <td class="tg-s6z2"><br></td>
 
-
    <td class="tg-u8t5"><br></td>
 
-
    <td class="tg-u8t5"><br></td>
 
   </tr>
   </tr>
</table>
</table>

Revision as of 01:23, 17 October 2014

EC 1.1.1.3 - Homoserine dehydrogenase



Submitted by: Validated Inhibitor Reversible
SDU-Denmark_2014


ETH_Zurich_2014


Imperial_2013